• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者抗凝预防指南的依从性:关于指南不依从程度及因素的叙述性综述

Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence.

作者信息

Gebreyohannes Eyob Alemayehu, Salter Sandra, Chalmers Leanne, Bereznicki Luke, Lee Kenneth

机构信息

Division of Pharmacy, School of Allied Health, Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia.

School of Pharmacy and Biomedical Sciences, Curtin University, Perth, WA, Australia.

出版信息

Am J Cardiovasc Drugs. 2021 Jul;21(4):419-433. doi: 10.1007/s40256-020-00457-3. Epub 2020 Dec 28.

DOI:10.1007/s40256-020-00457-3
PMID:33369718
Abstract

Atrial fibrillation is the most common arrhythmia. It increases the risk of thromboembolism by up to fivefold. Guidelines provide evidence-based recommendations to effectively mitigate thromboembolic events using oral anticoagulants while minimizing the risk of bleeding. This review focuses on non-adherence to contemporary guidelines and the factors associated with guideline non-adherence. The extent of guideline non-adherence differs according to geographic region, healthcare setting, and risk stratification tools used. Guideline adherence has gradually improved over recent years, but a significant proportion of patients are still not receiving guideline-recommended therapy. Physician-related and patient-related factors (such as patient refusals, bleeding risk, older age, and recurrent falls) also contribute to guideline non-adherence, especially to undertreatment. Quality improvement initiatives that focus on undertreatment, especially in the primary healthcare setting, may help to improve guideline adherence.

摘要

心房颤动是最常见的心律失常。它会使血栓栓塞风险增加多达五倍。指南提供了基于证据的建议,以通过使用口服抗凝剂有效减轻血栓栓塞事件,同时将出血风险降至最低。本综述重点关注对当代指南的不依从性以及与指南不依从相关的因素。指南不依从的程度因地理区域、医疗环境和所使用的风险分层工具而异。近年来,指南依从性已逐渐改善,但仍有很大比例的患者未接受指南推荐的治疗。与医生和患者相关的因素(如患者拒绝、出血风险、老年和反复跌倒)也导致指南不依从,尤其是治疗不足。关注治疗不足的质量改进举措,特别是在初级医疗环境中,可能有助于提高指南依从性。

相似文献

1
Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence.心房颤动患者抗凝预防指南的依从性:关于指南不依从程度及因素的叙述性综述
Am J Cardiovasc Drugs. 2021 Jul;21(4):419-433. doi: 10.1007/s40256-020-00457-3. Epub 2020 Dec 28.
2
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.欧洲心脏病学会指南指导下的抗栓治疗改善了高危房颤患者的预后:来自 EORP-AF 一般试点登记处的报告。
Europace. 2015 Dec;17(12):1777-86. doi: 10.1093/europace/euv269. Epub 2015 Aug 30.
3
Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.出院时房颤患者遵循指南指导的抗栓治疗情况评估。
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):502-508. doi: 10.1177/1074248418778804. Epub 2018 May 27.
4
Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.中国非瓣膜性心房颤动急性缺血性脑卒中患者出院时华法林的使用情况。
Stroke. 2016 Feb;47(2):464-70. doi: 10.1161/STROKEAHA.115.011833. Epub 2015 Dec 22.
5
The Effect of a Clinical Decision Support System on Improving Adherence to Guideline in the Treatment of Atrial Fibrillation: An Interrupted Time Series Study.临床决策支持系统对改善心房颤动治疗指南依从性的影响:一项中断时间序列研究。
J Med Syst. 2017 Dec 23;42(2):26. doi: 10.1007/s10916-017-0881-6.
6
Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.意大利初级保健医生对心房颤动的诊断和管理:一项回顾性、观察性分析。
Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5.
7
Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.新西兰初级医疗保健中的心房颤动:患病率、中风风险因素及血栓栓塞风险的管理
Eur J Prev Cardiol. 2017 Feb;24(3):311-319. doi: 10.1177/2047487316674830. Epub 2016 Oct 22.
8
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.遵循抗血栓治疗指南可改善老年房颤患者的死亡率:来自REPOSI研究的见解。
Clin Res Cardiol. 2016 Nov;105(11):912-920. doi: 10.1007/s00392-016-0999-4. Epub 2016 May 31.
9
Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.2014 年美国心脏协会/美国心脏病学会/心律学会指南新推荐口服抗凝治疗的心房颤动患者的结局。
J Am Heart Assoc. 2018 Jan 4;7(1):e007881. doi: 10.1161/JAHA.117.007881.
10
Anticoagulation therapy in elderly patients with atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate the Implementation of New Guidelines (RAFTING).老年心房颤动患者的抗凝治疗:心房颤动新指南实施调查登记研究(RAFTING)的结果
J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):545-549. doi: 10.2459/JCM.0000000000000355.

引用本文的文献

1
Design and Evaluation of ACAFiB-APP, a clinical decision support system for anticoagulant considerations in patients with atrial fibrillation.ACAFiB-APP的设计与评估,一种用于心房颤动患者抗凝治疗考量的临床决策支持系统。
BMC Cardiovasc Disord. 2025 Mar 8;25(1):166. doi: 10.1186/s12872-025-04615-w.
2
Clinical decision support systems to optimize adherence to anticoagulant guidelines in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.优化心房颤动患者抗凝指南依从性的临床决策支持系统:随机对照试验的系统评价和荟萃分析
Thromb J. 2024 May 28;22(1):45. doi: 10.1186/s12959-024-00614-7.
3

本文引用的文献

1
Adherence to guidelines regarding anticoagulation and risk factors for progression of atrial fibrillation in a nurse-led clinic.抗凝治疗和房颤进展的危险因素的指南依从性在护士主导的诊所中。
Intern Med J. 2021 Jul;51(7):1136-1142. doi: 10.1111/imj.14874.
2
Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.澳大利亚昆士兰州东南部房颤住院期间抗凝治疗的起始情况
Heart Lung Circ. 2020 Sep;29(9):e222-e230. doi: 10.1016/j.hlc.2020.03.009. Epub 2020 Apr 1.
3
Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry.
Racial and sex differences in optimizing anticoagulation therapy for patients with atrial fibrillation.
心房颤动患者优化抗凝治疗中的种族和性别差异。
Am Heart J Plus. 2022 Jul 2;18:100170. doi: 10.1016/j.ahjo.2022.100170. eCollection 2022 Jun.
4
How well do ED physician practices align with the CAEP acute atrial fibrillation checklist for stroke prevention and disposition?ED 医师的实践与 CAEP 急性心房颤动预防和处置检查表的吻合程度如何?
CJEM. 2024 May;26(5):327-332. doi: 10.1007/s43678-024-00676-6. Epub 2024 Mar 26.
5
Patients' Perspectives on Commencing Oral Anticoagulants in Atrial Fibrillation: An Exploratory Qualitative Descriptive Study.房颤患者对开始口服抗凝剂治疗的看法:一项探索性定性描述性研究。
Pharmacy (Basel). 2023 Sep 23;11(5):153. doi: 10.3390/pharmacy11050153.
6
Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications.低卒中风险及相关出血并发症的心房颤动患者口服抗凝药的使用
J Clin Med. 2023 Sep 25;12(19):6182. doi: 10.3390/jcm12196182.
7
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.心房颤动与卒中预防:《欧洲心脏杂志》 25 年研究成果
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad226.
8
A Survey of Saudi General Practitioners on the Use of Thromboprophylaxis Guidelines and Risk Assessment Tools in Atrial Fibrillation.一项关于沙特全科医生对心房颤动血栓预防指南和风险评估工具使用情况的调查。
Clin Pract. 2023 Feb 23;13(2):347-356. doi: 10.3390/clinpract13020031.
9
Use of thromboprophylaxis guidelines and risk stratification tools in atrial fibrillation: A survey of general practitioners in Australia.房颤患者中抗栓治疗指南和风险评估工具的应用:澳大利亚全科医生的调查。
J Eval Clin Pract. 2022 Jun;28(3):483-492. doi: 10.1111/jep.13685. Epub 2022 Apr 6.
10
Efficacy and Safety of Catheter Ablation Combined with Left Atrial Appendage Closure in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis.导管消融联合左心耳封堵术治疗心房颤动的疗效和安全性:系统评价和荟萃分析。
Anatol J Cardiol. 2022 Mar;26(3):154-162. doi: 10.5152/AnatolJCardiol.2021.766.
荷兰近期发生房颤患者抗凝处方的变化:来自GARFIELD-AF注册研究的观察结果
Thromb J. 2020 Mar 30;18:5. doi: 10.1186/s12959-020-00218-x. eCollection 2020.
4
Why are antithrombotic drugs not prescribed to octogenarian patients with atrial fibrillation at risk of stroke?为什么不向有中风风险的 80 岁以上房颤老年患者开具抗血栓药物?
Semergen. 2020 Sep;46(6):392-399. doi: 10.1016/j.semerg.2020.02.001. Epub 2020 Mar 28.
5
Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region - Analysis Using the National Health Insurance Database.日本某地区非瓣膜性心房颤动患病率及抗凝治疗趋势分析——基于国民健康保险数据库的研究
Circ J. 2020 Apr 24;84(5):706-713. doi: 10.1253/circj.CJ-18-0989. Epub 2020 Mar 25.
6
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.以色列诊断为心房颤动后 3 个月内口服抗凝治疗的使用情况:一项基于人群的研究。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1356-1363. doi: 10.1111/jce.14452. Epub 2020 Apr 1.
7
Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.从英国和日本 AF 登记处的房颤患者的中风和死亡来看,指南一致的治疗方法。
Circ J. 2019 Nov 25;83(12):2434-2442. doi: 10.1253/circj.CJ-19-0546. Epub 2019 Nov 6.
8
Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal.降低心房颤动患者的中风风险:对指南的遵循情况有所改善,但患者抗凝治疗的持续性仍不理想。
Korean Circ J. 2019 Oct;49(10):883-907. doi: 10.4070/kcj.2019.0234.
9
Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.韩国非瓣膜性心房颤动患者中口服抗凝剂的应用。
Int J Clin Pharm. 2019 Dec;41(6):1434-1441. doi: 10.1007/s11096-019-00901-8. Epub 2019 Sep 14.
10
Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.心房颤动的卒中预防?开还是不开处方——对急诊科提供者决策过程的定性研究。
Ann Emerg Med. 2019 Dec;74(6):759-771. doi: 10.1016/j.annemergmed.2019.03.026. Epub 2019 May 9.